From October 30, 2021 to January 28, 2022, the company has repurchased 3,433,500 shares, representing 0.26% for $371.3 million. With this, the company has completed the repurchase of 67,667,007 shares, representing 5.02% for $6,649.18 million under the buyback announced on June 23, 2017.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
80.38 USD | -1.12% | +1.64% | -2.43% |
Apr. 23 | Edwards Lifesciences Corporation: The story continues | |
Apr. 17 | Baird Adjusts Medtronic Price Target to $88 From $91 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.43% | 107B | |
-2.89% | 185B | |
-4.10% | 67.55B | |
+11.10% | 54.6B | |
+15.86% | 47.42B | |
+3.86% | 42.24B | |
+9.55% | 28.24B | |
+1.85% | 26.42B | |
+12.40% | 25.66B | |
-0.44% | 24.9B |
- Stock Market
- Equities
- MDT Stock
- News Medtronic plc
- Tranche Update on Medtronic plc's Equity Buyback Plan announced on June 23, 2017.